1. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells
    Cyndia Charfi et al, 2021, Frontiers in Oncology CrossRef

  2. Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?


    Heng Cai et al, 2020, OncoTargets and Therapy CrossRef
  3. Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
    Amirhossein Sheida et al, 2024, Cell Biochemistry and Biophysics CrossRef
  4. Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma
    Yue Chong et al, 2024, Current Cancer Drug Targets CrossRef
  5. An aqueous extract from toad skin prevents gelatinase activities derived from fetal serum albumin and serum-free culture medium of human breast carcinoma MDA-MB-231 cells
    Munehiro Nakata et al, 2015, Drug Discoveries & Therapeutics CrossRef
  6. Curcumin prevents lipopolysaccharide-induced matrix metalloproteinase-2 activity via the Ras/MEK1/2 signaling pathway in rat vascular smooth muscle cells
    Yi Zhong et al, 2017, Molecular Medicine Reports CrossRef
  7. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment
    Shuixian Li et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  8. Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
    Ruoling Gao et al, 2022, Journal of Nanobiotechnology CrossRef